Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |